There is no convincing evidence that zinc supplementation to infants or children results in improved motor or mental development
BACKGROUND Zinc deficiency is a significant public health problem in low- and middle-income countries .
Zinc is essential for the formation and migration of neurons along with the formation of neuronal synapses .
Its deficiency could interfere with the formation of neural pathways and with neurotransmission , thus affecting behavior ( for example , attention , activity , engagement , temperament ) and development ( for example , gross and fine motor skills , social skills ) .
Zinc supplementation provided to infants and children is a possible strategy to improve the mental and motor development of infants and children at high risk of zinc deficiency .
OBJECTIVES To assess the effects of zinc supplementation compared to placebo on measures of psychomotor development or cognitive function in children .
Combined iron and folic acid supplementation with or without zinc reduces time to walking unassisted among Zanzibari infants 5- to 11-mo old.
Iron and zinc deficiencies have been associated with delayed motor development in nutritionally at-risk children , albeit inconsistently . In this community-based , r and omized double-blind trial , iron+folic acid ( FeFA ) ( 12.5 mg Fe + 50 mug folic acid ) , zinc ( Zn ) ( 10 mg ) , and iron+folic acid+zinc ( FeFA+Zn ) supplements or a placebo were given daily for 1 y to nutritionally at-risk children in Pemba , Zanzibar . The effects of these treatments on attaining unassisted walking were evaluated using survival analysis for 354 children aged 5 - 11 mo at the start of supplementation . Treatment effects on changes in hemoglobin ( Hb ) and zinc protoporphyrin ( ZPP ) and height-for-age ( HAZ ) and weight-for-age ( WAZ ) Z scores were evaluated using linear regression . Attained motor milestone was recorded every 2 wk for 1 y. Hb , ZPP , HAZ , and WAZ were measured at baseline and after 6 mo of treatment . FeFA with or without Zn reduced the time it took for children to walk assisted . Children who received any iron  walked unassisted sooner than those who received no iron [ median difference approximately 15 d , P = 0.035 , risk ratio ( RR ) = 1.28 , 95 % CI = 1.02 , 1.61 ] and this effect was stronger in those who had iron deficiency anemia ( IDA ) at baseline ( median difference was approximately 30 d ; P = 0.002 ; RR = 1.68 ; 95 % CI = 1.21 , 2.32 ) . FeFA alone and Zn alone improved Hb and ZPP compared with placebo . There were no significant treatment effects on changes in HAZ or WAZ . The effects of treatment on time to walking may have been mediated by improvements in iron status or hemoglobin , but were not mediated through improvements in growth
There is no convincing evidence that zinc supplementation to infants or children results in improved motor or mental development
BACKGROUND Zinc deficiency is a significant public health problem in low- and middle-income countries .
Zinc is essential for the formation and migration of neurons along with the formation of neuronal synapses .
Its deficiency could interfere with the formation of neural pathways and with neurotransmission , thus affecting behavior ( for example , attention , activity , engagement , temperament ) and development ( for example , gross and fine motor skills , social skills ) .
Zinc supplementation provided to infants and children is a possible strategy to improve the mental and motor development of infants and children at high risk of zinc deficiency .
OBJECTIVES To assess the effects of zinc supplementation compared to placebo on measures of psychomotor development or cognitive function in children .